DUXAP8 knockdown inhibits the development of melanoma by regulating the miR-3182/NUPR1 pathway

Xige Chen1, Juan Gao1, Ning Liang2

  • 1Department of Dermatology, Weihai Central Hospital, Weihai, Shandong 264400, P.R. China.

Oncology Letters
|May 13, 2021
PubMed

Insights

Double homeobox A pseudogene 8 (DUXAP8) promotes melanoma growth. Downregulating DUXAP8 inhibits cancer progression by affecting the miR-3182/NUPR1 pathway, offering a potential therapeutic target for melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The role of Double homeobox A pseudogene 8 (DUXAP8) in melanoma progression is not well understood.
  • Previous studies indicate DUXAP8's involvement in other cancer types.

Purpose of the Study:

  • To investigate the mechanism by which DUXAP8 influences melanoma progression.
  • To explore the relationship between DUXAP8, miR-3182, and NUPR1 in melanoma.

Main Methods:

  • Quantitative reverse transcription-PCR (RT-qPCR) for DUXAP8 expression analysis.
  • Kaplan-Meier survival analysis and Pearson's correlation for prognostic and relational insights.
  • Luciferase reporter assays, RNA pull-down, Cell Counting-Kit-8, and Transwell assays to elucidate molecular interactions and cellular behaviors.

Main Results:

  • DUXAP8 was found to be upregulated in melanoma tissues and cells.
  • Higher DUXAP8 levels correlated with shorter patient survival times.
  • Knockdown of DUXAP8 suppressed melanoma cell proliferation, migration, and invasion.
  • DUXAP8 targets miR-3182, which in turn targets NUPR1; NUPR1 overexpression counteracted DUXAP8 knockdown effects.

Conclusions:

  • DUXAP8 acts as an oncogenic lncRNA in melanoma.
  • Downregulation of DUXAP8 inhibits melanoma development via the miR-3182/NUPR1 axis.
  • Targeting the DUXAP8/miR-3182/NUPR1 pathway presents a potential therapeutic strategy for melanoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K